Figure 2.

Validation scheme for drug repositioning predictions. We identify a score cutoff that yields the best P-value against drug indication originating from single textual indication source (low confidence) (A). Applying the cutoff, we validate the selected top ranking predictions against indications under test in clinical trials (B) and the co-occurrence of drug targets and indicated diseases in the same tissues (C).